Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ2002; 324: 71–86
2.
SmoutJ, StansbyG. Current practice in the use of antiplatelet agents in the peri-operative period by UK vascular surgeons. Ann Roy Coll Surg2003; 85: 97–101
Reviews and Notes: Pharmacology: Beneficial and Toxic Effects of Aspirin. Ann Intern Med1994; 121: 999
5.
NguyenTA, DiodatiJG, PharandC. Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol2005; 45: 1157–64
6.
JernbergT, PayneCD, WintersKJ, Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. Eur Heart J2006; 27: 1166–73
7.
HankeyGJ. Review: dipyridamole given with or without aspirin reduces recurrent stroke. ACP J Club2005; 143: 10
8.
BlannAD, LandrayMJ, LipGYH. ABC of antithrombotic therapy: An overview of antithrombotic therapy. BMJ2002; 325: 762–5
9.
ThompsonPD, ZimetR, ForbesWP, ZhangP. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol2002; 90: 1314–19
10.
IwamotoT, KinK, MiyazakiK, ShinK, TakasakiM. Recovery of platelet function after withdrawal of cilostazol administered orally for a long period. J Atherosclerosis Thromb2003; 10: 348–54
11.
RoblessP, MikhailidisDP, StansbyG. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg2001; 88: 787–800
12.
SchoutenO, DunkelgrunM, FeringaHH, Myocardial damage in high-risk patients undergoing elective endovascular or open infrarenal abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg2007; 33: 544–9
13.
KimHL, ParkKW, KwakJJ, Stent-related cardiac events after non-cardiac surgery: drug-eluting stent vs. bare metal stent. Int J Cardiol2008; 123: 353–4
14.
GodetG, Le ManachY, LesacheF, PerbetS, CoriatP. Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery: is it always a problem?Br J of Anaesthesia2008; 100: 472–7
15.
KaluzaGL, JosephJ, LeeJR, RaiznerME, RaiznerAE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol2000; 35: 1288–94
16.
WilsonSH, FasseasP, OrfordJL, Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol2003; 42: 234–40
17.
WilhiteDB, ComerotaAJ, SchmiederFA, ThromRC, GaughanJP, RaoAK. Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time. J Vasc Surg2003; 38: 710–13
18.
TamNL, Pac-SooC, PretoriusPM. Epidural haematoma after a combined spinal-epidural anaesthetic in a patient treated with clopidogrel and dalteparin. Br J Anaesthesia2006; 96: 262–5
19.
DaceyLJ, MunozJJ, JohnsonER, ; Northern New England Cardiovascular Disease Study G. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients.[see comment]. Ann Thorac Surg2000; 70: 1986–90
20.
CovinR, O'BrienM, GrunwaldG, Factors affecting transfusion of fresh frozen plasma, platelets, and red blood cells during elective coronary artery bypass graft surgery. Arch Pathol Lab Med2003; 127: 415–23
21.
BjessmoS, IvertT. Blood loss after coronary artery bypass surgery: relations to patient variables and antithrombotic treatment. Scand Cardiovasc J2000; 34: 438–45
22.
ParrKG, PatelMA, DekkerR, Multivariate predictors of blood product use in cardiac surgery. J Cardiothor Vasc Anesth2003; 17: 176–81
23.
FerrarisVA, FerrarisSP, JosephO, WehnerP, MentzerRMJr.Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg2002; 235: 820–7
24.
FerrarisVA, FerrarisSP, MoliternoDJ, The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and Other Antiplatelet Agents During Operative Coronary Revascularization (Executive Summary). Ann Thorac Surg2005; 79: 1454–61
BhattDL, HirschAT, RinglebPA, HackeW, TopolEJ. Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators. Am Heart J2000; 140: 67–73
27.
The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of Clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med2001; 345: 494–502
28.
CriadoA, JuffeA, CarmonaJ, OteroC, AvelloF. Ticlopidine as a hemorrhagic risk factor in coronary surgery. Drug Intell Clin Pharm1985; 19: 673–6
29.
NevelsteenA, MortelmansL, Van de CruysA, MerckxE, VerhaegheR. Effect of ticlopidine on blood loss, platelet turnover and platelet deposition on prosthetic surfaces in patients undergoing aorto-femoral bypass grafting. Thromb Res1991; 64: 363–9
30.
PayneDA, HayesPD, JonesCI, BelhamP, NaylorAR, GoodallAH. Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action. J Vasc Surg2002; 35: 1204–9
31.
YendeS, WunderinkRG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med2001; 29: 2271–5
32.
HongoRH, LeyJ, DickSE, YeeRR. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting.[see comment]. J Am Coll Cardiol2002; 40: 231–7
33.
RayJG, DenizS, OlivieriA, Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel. BMC Cardiovasc Disord2003; 3: 3
34.
GanseraB, SchmidtlerF, SpiliopoulosK, AngelisI, Neumaier-PrauserP, KemkesBM. Urgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapy. Thorac Cardiovasc Surg2003; 51: 185–9
35.
ChuMWA, WilsonSR, NovickRJ, StittLW, QuantzMA. Does Clopidogrel increase blood loss following coronary artery bypass surgery?Ann Thorac Surg2004; 78: 1536–41
36.
HekmatK, MenzelC, KroenerA, The effect of preoperative antiplatelet therapy in coronary artery surgery: blood transfusion requirements for patients on cardiopulmonary bypass. Curr Med Res Opin2004; 20: 1429–35
37.
ChenL, BraceyAW, RadovancevicR, Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg2004; 128: 425–31
KapetanakisEI, MedlamDA, BoyceSW, Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?Eur Heart J2005; 26: 576–83
40.
AscioneR, GhoshA, RogersCA, CohenA, MonkC, AngeliniGD. In-hospital patients exposed to Clopidogrel before coronary artery bypass graft surgery: a word of caution. Ann Thorac Surg2005; 79: 1210–16
41.
KimJ-S, LeeK-S, KimY-I, TamaiY, NakahataR, TakamiH. A randomized crossover comparative study of aspirin, cilostazol and clopidogrel in normal controls: analysis with quantitative bleeding time and platelet aggregation test. J Clin Neurosci2004; 11: 600–2
42.
TamaiY, TakamiH, NakahataR, OnoF, MunakataA. Comparison of the effects of acetylsalicylic acid, ticlopidine and cilostazol on primary hemostasis using a quantitative bleeding time test apparatus. Haemostasis1999; 29: 269–76
43.
Biondi-ZoccaiGG, LotrionteM, AnselminoM, Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention. Am Heart J2008; 155: 1081–89
